首页 > 最新文献

Zhonghua wei zhong bing ji jiu yi xue最新文献

英文 中文
[Expert consensus on diagnosis and treatment of intra-abdominal candidiasis in critically ill patients (2025 edition)]. 【危重患者腹腔内念珠菌病诊治专家共识(2025年版)】。
Q3 Medicine Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn121430-20250304-00213
Care Critical Care Medicine Committee Of China International Exchange And Promotive Association For Medical And Health, Association Hospital Pharmacy Committee Of China Pharmaceutical

Extracorporeal membrane oxygenation (ECMO) technology is an important life support method for critically ill patients. A large number of studies have found that ECMO can change the pharmacokinetic (PK) parameters of critically ill patients, thereby affecting the drug effect in vivo. However, there is still a lack of recommendations for the adjustment of commonly used drugs during ECMO support in China, and the selection or dosage adjustment of drugs during ECMO support is not clear. Therefore, a multidisciplinary group of domestic experts in clinical pharmacy and critical care medicine was established by Critical Care Medicine Committee of China International Exchange and Promotive Association for Medical and Health Care, and Hospital Pharmacy Committee of China Pharmaceutical Association, to develop the Expert consensus on drug adjustment during extracorporeal membrane oxygenation support (2025). Eight clinical issues of drug adjustment during ECMO support were discussed in this consensus: (1) Why does the patient's demand for drug dosage change during ECMO support? (2) What factors are related to the degree of drug loss during ECMO support? (3) Considering the features of drugs, which types of drugs may need to be adjusted during ECMO support? (4) How to adjust the dosage when using antibacterial drugs during ECMO support? (5) How to adjust antifungal drugs during ECMO support? (6) Does ECMO support change patients' dosage requirements for antiviral drugs? (7) How to adjust sedative and analgesic drugs during ECMO support? (8) Does ECMO support affect the dosage requirement of vasoactive agents? Eighteen consensus are elaborated based on the latest clinical evidence, aiming to provide recommendations for drug adjustment in critically ill patients receiving ECMO support to ensure the safety and effectiveness of medication.

体外膜氧合(Extracorporeal membrane oxygenation, ECMO)技术是危重患者重要的生命支持手段。大量研究发现,ECMO可以改变危重患者的药代动力学(PK)参数,从而影响药物在体内的作用。但目前国内对于ECMO支持期间常用药物的调整仍缺乏建议,ECMO支持期间药物的选择或剂量调整也不明确。为此,由中国医疗卫生国际交流与促进协会危重医学专业委员会、中国药学会医院药学专业委员会联合成立国内临床药学与危重医学多学科专家组,制定《体外膜氧合支持期间药物调整专家共识(2025)》。本共识讨论了ECMO支持期间药物调整的8个临床问题:(1)为什么患者在ECMO支持期间对药物剂量的需求会发生变化?(2) ECMO支持过程中与药物损失程度相关的因素有哪些?(3)考虑到药物的特点,哪些药物在ECMO支持期间可能需要调整?(4) ECMO支持期间抗菌药物的用量如何调整?(5) ECMO支持期间如何调整抗真菌药物?(6) ECMO是否支持改变患者抗病毒药物的剂量要求?(7) ECMO支持时镇静镇痛药物如何调整?(8) ECMO支持是否影响血管活性药物的剂量要求?根据最新的临床证据,阐述了18项共识,旨在为危重患者接受ECMO支持时的药物调整提供建议,以确保用药的安全性和有效性。
{"title":"[Expert consensus on diagnosis and treatment of intra-abdominal candidiasis in critically ill patients (2025 edition)].","authors":"Care Critical Care Medicine Committee Of China International Exchange And Promotive Association For Medical And Health, Association Hospital Pharmacy Committee Of China Pharmaceutical","doi":"10.3760/cma.j.cn121430-20250304-00213","DOIUrl":"10.3760/cma.j.cn121430-20250304-00213","url":null,"abstract":"<p><p>Extracorporeal membrane oxygenation (ECMO) technology is an important life support method for critically ill patients. A large number of studies have found that ECMO can change the pharmacokinetic (PK) parameters of critically ill patients, thereby affecting the drug effect in vivo. However, there is still a lack of recommendations for the adjustment of commonly used drugs during ECMO support in China, and the selection or dosage adjustment of drugs during ECMO support is not clear. Therefore, a multidisciplinary group of domestic experts in clinical pharmacy and critical care medicine was established by Critical Care Medicine Committee of China International Exchange and Promotive Association for Medical and Health Care, and Hospital Pharmacy Committee of China Pharmaceutical Association, to develop the Expert consensus on drug adjustment during extracorporeal membrane oxygenation support (2025). Eight clinical issues of drug adjustment during ECMO support were discussed in this consensus: (1) Why does the patient's demand for drug dosage change during ECMO support? (2) What factors are related to the degree of drug loss during ECMO support? (3) Considering the features of drugs, which types of drugs may need to be adjusted during ECMO support? (4) How to adjust the dosage when using antibacterial drugs during ECMO support? (5) How to adjust antifungal drugs during ECMO support? (6) Does ECMO support change patients' dosage requirements for antiviral drugs? (7) How to adjust sedative and analgesic drugs during ECMO support? (8) Does ECMO support affect the dosage requirement of vasoactive agents? Eighteen consensus are elaborated based on the latest clinical evidence, aiming to provide recommendations for drug adjustment in critically ill patients receiving ECMO support to ensure the safety and effectiveness of medication.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 7","pages":"605-619"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mechanism of auraptene in improving acute liver injury induced by diquat poisoning in mice]. [auraptene改善diquat中毒小鼠急性肝损伤的机制]。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20250113-00043
Renyang Ou, Shan Huang, Lihong Ma, Zhijie Zhao, Shengshan Liu, Yuanliang Wang, Yezi Sun, Nana Xu, Lijun Zhou, Mei Li, Manhong Zhou, Guosheng Rao
<p><strong>Objective: </strong>To investigate whether auraptene (AUR) exerts a protective effect on acute diquat (DQ)-induced liver injury in mice and explore its underlying mechanisms.</p><p><strong>Methods: </strong>Forty SPF-grade healthy male C57BL/6 mice were randomly divided into normal control group (Control group), DQ poisoning model group (DQ group), AUR treatment group (DQ+AUR group), and AUR control group (AUR group), with 10 mice in each group. The DQ poisoning model was established via a single intraperitoneal injection of 40 mg/kg DQ aqueous solution (0.5 mL); Control group and AUR group received an equal volume of pure water intraperitoneally. Four hours post-modeling, DQ+AUR group and AUR group were administered 0.5 mg/kg AUR aqueous solution (0.2 mL) by gavage once daily for 7 consecutive days, while Control group and DQ group received pure water. Blood and liver tissues were collected after anesthesia on day 7. Liver ultrastructure was observed by transmission electron microscopy. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured via enzyme-linked immunosorbent assay (ELISA). Hepatic glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde (MDA) levels were detected using WST-1, thiobarbituric acid (TBA), and enzymatic reaction methods, respectively. Protein expression of nuclear factor-erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), Kelch-like ECH-associated protein 1 (Keap1), and activated caspase-9 in liver tissues was analyzed by Western blotting.</p><p><strong>Results: </strong>Transmission electron microscopy revealed that mitochondria in the Control group exhibited mild swelling, uneven distribution of matrix, and a small number of cristae fractures. In the AUR group, mitochondria showed mild swelling, with no obvious disruption of cristae structure. In the DQ group, mitochondria demonstrated marked swelling and increased volume, matrix dissolution, loss and fragmentation of cristae, and extensive vacuolization. In contrast, the DQ+AUR group showed significantly reduced mitochondrial swelling, volume increase, matrix dissolution, cristae loss and fragmentation, and vacuolization compared to the DQ group. Compared with the DQ group, the DQ+AUR group exhibited significantly lower serum AST levels (U/L: 173.45±23.60 vs. 255.33±41.51), ALT levels (U/L: 51.77±21.63 vs. 100.70±32.35), and hepatic MDA levels (μmol/g: 12.40±2.76 vs. 19.74±4.10), along with higher hepatic GSH levels (mmol/g: 37.65±14.95 vs. 20.58±8.52) and SOD levels (kU/g: 124.10±33.77 vs. 82.81±22.00), the differences were statistically significant (all P < 0.05). Western blotting showed upregulated Nrf2 expression (Nrf2/β-actin: 0.87±0.37 vs. 0.53±0.22) and HO-1 expression (HO-1/β-actin: 1.06±0.22 vs. 0.49±0.08), and downregulated Keap1 expression (Keap1/β-actin: 0.82±0.12 vs. 1.52±0.76) and activated caspase-9 expression (activated caspase-9/β-actin: 1.16±0.28 vs. 1.71±0.30) in the DQ+AUR gro
目的:观察auraptene (AUR)是否对急性diquat (DQ)诱导的小鼠肝损伤具有保护作用,并探讨其机制。方法:选取spf级健康雄性C57BL/6小鼠40只,随机分为正常对照组(control control组)、DQ中毒模型组(DQ组)、AUR治疗组(DQ+AUR组)和AUR对照组(AUR组),每组10只。采用单次腹腔注射40 mg/kg DQ水溶液(0.5 mL)建立DQ中毒模型;对照组和AUR组均给予等量纯净水腹腔注射。造模后4 h, DQ+AUR组和AUR组给予AUR水溶液0.5 mg/kg (0.2 mL),每天1次灌胃,连续7 d,对照组和DQ组给予纯净水。第7天麻醉后取血和肝组织。透射电镜观察肝脏超微结构。采用酶联免疫吸附法(ELISA)测定血清谷丙转氨酶(ALT)和天冬氨酸转氨酶(AST)水平。采用WST-1、硫代巴比妥酸(TBA)和酶促反应法分别检测肝脏谷胱甘肽(GSH)、超氧化物歧化酶(SOD)和丙二醛(MDA)水平。Western blotting检测肝组织中核因子-红细胞2相关因子2 (Nrf2)、血红素加氧酶-1 (HO-1)、kelch样ECH-associated Protein 1 (Keap1)、活化caspase-9的蛋白表达。结果:透射电镜显示,对照组线粒体轻度肿胀,基质分布不均匀,少量嵴骨折。AUR组线粒体轻度肿胀,嵴结构未见明显破坏。在DQ组,线粒体表现出明显的肿胀和体积增加,基质溶解,嵴丢失和破碎,广泛的空泡化。相比之下,DQ+AUR组与DQ组相比,线粒体肿胀、体积增加、基质溶解、嵴丢失和断裂以及空泡化明显减少。与DQ组比较,DQ+AUR组血清AST水平(U/L: 173.45±23.60∶255.33±41.51)、ALT水平(U/L: 51.77±21.63∶100.70±32.35)、MDA水平(μmol/g: 12.40±2.76∶19.74±4.10)显著降低,GSH水平(mmol/g: 37.65±14.95∶20.58±8.52)、SOD水平(kU/g: 124.10±33.77∶82.81±22.00)显著升高,差异均有统计学意义(P均< 0.05)。Western blot结果显示,DQ+AUR组Nrf2表达上调(Nrf2/β-actin: 0.87±0.37比0.53±0.22),HO-1表达上调(HO-1/β-actin: 1.06±0.22比0.49±0.08),Keap1表达下调(Keap1/β-actin: 0.82±0.12比1.52±0.76),活化caspase-9表达下调(活化caspase-9/β-actin: 1.16±0.28比1.71±0.30)(均P < 0.05)。结论:AUR通过激活Keap1/Nrf2信号通路减轻dq诱导的小鼠急性肝损伤。
{"title":"[Mechanism of auraptene in improving acute liver injury induced by diquat poisoning in mice].","authors":"Renyang Ou, Shan Huang, Lihong Ma, Zhijie Zhao, Shengshan Liu, Yuanliang Wang, Yezi Sun, Nana Xu, Lijun Zhou, Mei Li, Manhong Zhou, Guosheng Rao","doi":"10.3760/cma.j.cn121430-20250113-00043","DOIUrl":"10.3760/cma.j.cn121430-20250113-00043","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate whether auraptene (AUR) exerts a protective effect on acute diquat (DQ)-induced liver injury in mice and explore its underlying mechanisms.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Forty SPF-grade healthy male C57BL/6 mice were randomly divided into normal control group (Control group), DQ poisoning model group (DQ group), AUR treatment group (DQ+AUR group), and AUR control group (AUR group), with 10 mice in each group. The DQ poisoning model was established via a single intraperitoneal injection of 40 mg/kg DQ aqueous solution (0.5 mL); Control group and AUR group received an equal volume of pure water intraperitoneally. Four hours post-modeling, DQ+AUR group and AUR group were administered 0.5 mg/kg AUR aqueous solution (0.2 mL) by gavage once daily for 7 consecutive days, while Control group and DQ group received pure water. Blood and liver tissues were collected after anesthesia on day 7. Liver ultrastructure was observed by transmission electron microscopy. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured via enzyme-linked immunosorbent assay (ELISA). Hepatic glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde (MDA) levels were detected using WST-1, thiobarbituric acid (TBA), and enzymatic reaction methods, respectively. Protein expression of nuclear factor-erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), Kelch-like ECH-associated protein 1 (Keap1), and activated caspase-9 in liver tissues was analyzed by Western blotting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Transmission electron microscopy revealed that mitochondria in the Control group exhibited mild swelling, uneven distribution of matrix, and a small number of cristae fractures. In the AUR group, mitochondria showed mild swelling, with no obvious disruption of cristae structure. In the DQ group, mitochondria demonstrated marked swelling and increased volume, matrix dissolution, loss and fragmentation of cristae, and extensive vacuolization. In contrast, the DQ+AUR group showed significantly reduced mitochondrial swelling, volume increase, matrix dissolution, cristae loss and fragmentation, and vacuolization compared to the DQ group. Compared with the DQ group, the DQ+AUR group exhibited significantly lower serum AST levels (U/L: 173.45±23.60 vs. 255.33±41.51), ALT levels (U/L: 51.77±21.63 vs. 100.70±32.35), and hepatic MDA levels (μmol/g: 12.40±2.76 vs. 19.74±4.10), along with higher hepatic GSH levels (mmol/g: 37.65±14.95 vs. 20.58±8.52) and SOD levels (kU/g: 124.10±33.77 vs. 82.81±22.00), the differences were statistically significant (all P &lt; 0.05). Western blotting showed upregulated Nrf2 expression (Nrf2/β-actin: 0.87±0.37 vs. 0.53±0.22) and HO-1 expression (HO-1/β-actin: 1.06±0.22 vs. 0.49±0.08), and downregulated Keap1 expression (Keap1/β-actin: 0.82±0.12 vs. 1.52±0.76) and activated caspase-9 expression (activated caspase-9/β-actin: 1.16±0.28 vs. 1.71±0.30) in the DQ+AUR gro","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"590-594"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of risk factors for ventilator-associated pneumonia and its prognosis in patients with severe craniocerebral injury]. 重型颅脑损伤患者呼吸机相关性肺炎危险因素及预后分析
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20240419-00358
Qinghua Lin, Huili Guo, Lin Qu, Lianzhen Qi
<p><strong>Objective: </strong>To analyze the risk factors for ventilator-associated pneumonia (VAP) and its prognosis in patients with severe craniocerebral injury.</p><p><strong>Methods: </strong>A prospective observational study was conducted. Patients with severe craniocerebral injury admitted to the Second Affiliated Hospital of Xingtai Medical College from January 2020 to December 2022 were enrolled as the study subjects. Patients were divided into VAP group and non-VAP group based on the occurrence of VAP. VAP patients were further stratified into low-risk group [sequential organ failure assessment (SOFA) score 0-5], moderate-risk group (SOFA score 6-8), and high-risk group (SOFA score ≥ 9). General data, serological indicators [interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and signal transducer and activator of transcription 3 (STAT3)], and 28-day prognosis (with mortality as the endpoint event) were compared. Multivariate Logistic regression was used to identify risk factors for VAP and 28-day mortality. Linear regression was applied to analyze the correlations between risk factors and outcomes.</p><p><strong>Results: </strong>A total of 140 patients with severe craniocerebral injury were enrolled, including 49 in the VAP group and 91 in the non-VAP group. The primary cause of injury was traffic accidents, followed by falls and heavy object impacts. Among VAP patients, 38 survived and 11 died within 28 days; 112 were classified as low-risk, 25 as moderate-risk, and 12 as high-risk. Significant differences were observed in age, body mass index (BMI), smoking history, hypertension, diabetes, hyperlipidemia, length of hospital stay, duration of mechanical ventilation, serum albumin levels, and frequency of sputum suction among different subgroups. Serologically, IL-1β, TNF-α, IL-6, and STAT3 mRNA expression levels in the VAP group were significantly higher than those in the non-VAP group. Deceased VAP patients exhibited higher IL-1β, TNF-α, IL-6, and STAT3 mRNA levels compared to survivors. These biomarkers progressively increased from low-risk to high-risk subgroups. Multivariate Logistic regression identified age [odds ratio (OR) were 0.328 and 0.318], BMI (OR were 0.340 and 0.268), hypertension (OR were 0.275 and 0.245), diabetes (OR were 0.319 and 0.307), hyperlipidemia (OR were 0.228 and 0.235), smoking history (OR were 0.255 and 0.240), length of hospital stay (OR were 0.306 and 0.230), duration of mechanical ventilation (OR were 0.247 and 0.219), frequency of sputum suction (OR were 0.325 and 0.228), IL-1β (OR were 0.231 and 0.259), TNF-α (OR were 0.308 and 0.235), IL-6 (OR were 0.298 and 0.277), and STAT3 (OR were 0.259 and 0.265) as independent risk factors for both VAP occurrence and 28-day mortality (all P < 0.05). Correlation analysis revealed that serum albumin levels were negatively correlated with VAP occurrence and mortality (all P < 0.01), while other factors showed positive correlations (al
目的:分析重型颅脑损伤患者呼吸机相关性肺炎(VAP)的危险因素及预后。方法:采用前瞻性观察研究。选取2020年1月至2022年12月邢台医学院第二附属医院收治的重型颅脑损伤患者作为研究对象。根据VAP发生情况将患者分为VAP组和非VAP组。将VAP患者进一步分为低危组[SOFA评分0-5分]、中危组(SOFA评分6-8分)和高危组(SOFA评分≥9分)。比较一般资料、血清学指标[白细胞介素-6 (IL-6)、白细胞介素-1β (IL-1β)、肿瘤坏死因子-α (TNF-α)、转录信号传导和激活因子3 (STAT3)]和28天预后(以死亡率为终点事件)。采用多因素Logistic回归确定VAP和28天死亡率的危险因素。采用线性回归分析危险因素与预后的相关性。结果:共纳入140例重型颅脑损伤患者,其中VAP组49例,非VAP组91例。受伤的主要原因是交通事故,其次是坠落和重物撞击。VAP患者28天内存活38例,死亡11例;112例为低风险,25例为中等风险,12例为高风险。不同亚组患者在年龄、体重指数(BMI)、吸烟史、高血压、糖尿病、高脂血症、住院时间、机械通气时间、血清白蛋白水平、吸痰次数等方面均存在显著差异。血清学上,VAP组IL-1β、TNF-α、IL-6、STAT3 mRNA表达水平均显著高于非VAP组。与幸存者相比,死亡的VAP患者表现出更高的IL-1β、TNF-α、IL-6和STAT3 mRNA水平。这些生物标志物从低风险亚组逐渐增加到高风险亚组。多因素Logistic回归确定年龄[比值比(OR)分别为0.328和0.318]、BMI (OR分别为0.340和0.268)、高血压(OR分别为0.275和0.245)、糖尿病(OR分别为0.319和0.307)、高脂血症(OR分别为0.228和0.235)、吸烟史(OR分别为0.255和0.240)、住院时间(OR分别为0.306和0.230)、机械通气持续时间(OR分别为0.247和0.219)、吸痰频率(OR分别为0.325和0.228)、IL-1β (OR分别为0.231和0.259)、TNF-α (OR分别为0.308和0.235)、IL-6 (OR分别为0.298和0.277)和STAT3 (OR分别为0.259和0.265)是VAP发生和28天死亡率的独立危险因素(均P < 0.05)。相关性分析显示血清白蛋白水平与VAP的发生、死亡率呈负相关(P < 0.01),其他因素呈正相关(P < 0.01)。结论:年龄、BMI、住院时间、机械通气时间、吸痰次数、高血压、糖尿病、高脂血症、吸烟史、IL-1β、TNF-α、IL-6/STAT3信号通路激活与重型颅脑损伤患者VAP发生及预后不良有显著相关性,为临床针对性干预提供了科学依据。
{"title":"[Analysis of risk factors for ventilator-associated pneumonia and its prognosis in patients with severe craniocerebral injury].","authors":"Qinghua Lin, Huili Guo, Lin Qu, Lianzhen Qi","doi":"10.3760/cma.j.cn121430-20240419-00358","DOIUrl":"10.3760/cma.j.cn121430-20240419-00358","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To analyze the risk factors for ventilator-associated pneumonia (VAP) and its prognosis in patients with severe craniocerebral injury.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A prospective observational study was conducted. Patients with severe craniocerebral injury admitted to the Second Affiliated Hospital of Xingtai Medical College from January 2020 to December 2022 were enrolled as the study subjects. Patients were divided into VAP group and non-VAP group based on the occurrence of VAP. VAP patients were further stratified into low-risk group [sequential organ failure assessment (SOFA) score 0-5], moderate-risk group (SOFA score 6-8), and high-risk group (SOFA score ≥ 9). General data, serological indicators [interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and signal transducer and activator of transcription 3 (STAT3)], and 28-day prognosis (with mortality as the endpoint event) were compared. Multivariate Logistic regression was used to identify risk factors for VAP and 28-day mortality. Linear regression was applied to analyze the correlations between risk factors and outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 140 patients with severe craniocerebral injury were enrolled, including 49 in the VAP group and 91 in the non-VAP group. The primary cause of injury was traffic accidents, followed by falls and heavy object impacts. Among VAP patients, 38 survived and 11 died within 28 days; 112 were classified as low-risk, 25 as moderate-risk, and 12 as high-risk. Significant differences were observed in age, body mass index (BMI), smoking history, hypertension, diabetes, hyperlipidemia, length of hospital stay, duration of mechanical ventilation, serum albumin levels, and frequency of sputum suction among different subgroups. Serologically, IL-1β, TNF-α, IL-6, and STAT3 mRNA expression levels in the VAP group were significantly higher than those in the non-VAP group. Deceased VAP patients exhibited higher IL-1β, TNF-α, IL-6, and STAT3 mRNA levels compared to survivors. These biomarkers progressively increased from low-risk to high-risk subgroups. Multivariate Logistic regression identified age [odds ratio (OR) were 0.328 and 0.318], BMI (OR were 0.340 and 0.268), hypertension (OR were 0.275 and 0.245), diabetes (OR were 0.319 and 0.307), hyperlipidemia (OR were 0.228 and 0.235), smoking history (OR were 0.255 and 0.240), length of hospital stay (OR were 0.306 and 0.230), duration of mechanical ventilation (OR were 0.247 and 0.219), frequency of sputum suction (OR were 0.325 and 0.228), IL-1β (OR were 0.231 and 0.259), TNF-α (OR were 0.308 and 0.235), IL-6 (OR were 0.298 and 0.277), and STAT3 (OR were 0.259 and 0.265) as independent risk factors for both VAP occurrence and 28-day mortality (all P &lt; 0.05). Correlation analysis revealed that serum albumin levels were negatively correlated with VAP occurrence and mortality (all P &lt; 0.01), while other factors showed positive correlations (al","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"549-554"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study on the effects of telomerase reverse transcriptase in alleviating doxorubicin induced cardiotoxicity]. [端粒酶逆转录酶在减轻阿霉素诱导心脏毒性中的作用研究]。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20240711-00582
Qingqing Gu, Qianwe Chen, Yu Wang, Dabei Cai, Tingting Xiao, Qingjie Wang, Ling Sun
<p><strong>Objective: </strong>To investigate the role of telomerase reverse transcriptase (TERT) in alleviating doxorubicin (DOX)-induced cardiotoxicity.</p><p><strong>Methods: </strong>(1) Cell experiments: rat H9c2 cardiomyocytes were divided into control group (CON group), null adenovirus transfection group (NC group), TERT overexpression adenovirus transfection group (TERT group), DOX group (treated with 1 μmol/L DOX for 12 hours), DOX+NC group, and DOX+TERT group (null adenovirus or TERT overexpression adenovirus were transfected for 24 hours and then treated with 1 μmol/L DOX for 12 hours). The mRNA expression of TERT in cardiomyocytes was detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR). The level of mitochondrial membrane potential was detected by immunofluorescence. The expression levels of intracellular Bax, Bcl-2, microtubule-associated protein 1 light chain 3 (LC3) and p62 were detected by Western blotting. (2) Animal experiments: male C57BL/6 mice were randomly divided into a sham operation group (Sham group), DOX group (acute cardiotoxicity model was constructed by intraperitoneal injection of DOX 15 mg/kg), DOX+NC group and DOX+TERT group (modeled after transfection with airborne adenovirus or TERT overexpression adenovirus for 7 days). After 7 days of modeling, the area of myocardial fibrosis was detected by Sirius scarlet staining, and cardiac function was detected by echocardiography.</p><p><strong>Results: </strong>(1) Cellular experiments: the mRNA expression level of TERT was significantly higher in the TERT group compared with the CON and NC groups. Compared with the CON group, the TERT mRNA expression level of cardiomyocytes in the DOX group and the DOX+NC group were significantly lower, the level of mitochondrial membrane potential was significantly lower, the protein expressions of Bax and LC3 were significantly increased, and the protein expressions of Bcl-2 and p62 were significantly decreased. No significant differences were found between the DOX group and DOX+NC group. Compared with the DOX group and DOX+NC group, the TERT mRNA expression level was increased in the DOX+TERT group (relative expression: 1.02±0.10 vs. 0.61±0.05, 0.54±0.03, both P < 0.05), the level of mitochondrial membrane potential was significantly increased (1.14±0.05 vs. 0.96±0.01, 0.96±0.01, both P < 0.05), the protein expressions of Bax and LC3 were significantly decreased, and the protein expressions of Bcl-2 and p62 were significantly increased (Bax/β-actin: 0.88±0.01 vs. 1.31±0.02, 1.26±0.01; LC3-II/I: 2.16±0.05 vs. 2.64±0.06, 2.58±0.02; Bcl-2/β-actin: 0.65±0.01 vs. 0.40±0.01, 0.41±0.01; p62/β-actin: 0.45±0.01 vs. 0.23±0.02, 0.29±0.01; all P < 0.05). (2) Animal experiments: compared with the Sham group, the percentage of myocardial fibrosis area was significantly increased and left ventricular ejection fraction (LVEF) and fractional shortening (FS) were significantly decreased in the DOX group and DOX+NC grou
目的:探讨端粒酶逆转录酶(TERT)在减轻多柔比星(DOX)诱导的心脏毒性中的作用。方法:(1)细胞实验:将大鼠H9c2心肌细胞分为对照组(CON组)、零腺病毒转染组(NC组)、TERT过表达腺病毒转染组(TERT过表达腺病毒转染组)、DOX组(1 μmol/L DOX处理12 h)、DOX+NC组和DOX+TERT组(零腺病毒或TERT过表达腺病毒转染24 h,再用1 μmol/L DOX处理12 h)。采用实时荧光定量聚合酶链反应(RT-qPCR)检测心肌细胞中TERT mRNA的表达。免疫荧光法检测线粒体膜电位水平。Western blotting检测细胞内Bax、Bcl-2、微管相关蛋白1轻链3 (LC3)和p62的表达水平。(2)动物实验:将雄性C57BL/6小鼠随机分为假手术组(sham组)、DOX组(通过腹腔注射DOX 15 mg/kg建立急性心脏毒性模型)、DOX+NC组和DOX+TERT组(通过空气传播腺病毒或TERT过表达腺病毒转染7 d建立模型)。造模7 d后,采用天狼星红染色法检测心肌纤维化面积,超声心动图检测心功能。结果:(1)细胞实验:与CON和NC组相比,TERT组TERT mRNA表达水平显著升高。与CON组相比,DOX组和DOX+NC组心肌细胞TERT mRNA表达水平显著降低,线粒体膜电位水平显著降低,Bax和LC3蛋白表达显著升高,Bcl-2和p62蛋白表达显著降低。DOX组与DOX+NC组无显著差异。与DOX组和DOX+NC组相比,DOX+TERT组TERT mRNA表达量升高(相对表达量:1.02±0.10比0.61±0.05,0.54±0.03,P均< 0.05),线粒体膜电位水平显著升高(1.14±0.05比0.96±0.01,0.96±0.01,P均< 0.05),Bax和LC3蛋白表达量显著降低,Bcl-2和p62蛋白表达量显著升高(Bax/β-actin:0.88±0.01 vs. 1.31±0.02,1.26±0.01;LC3-II/I: 2.16±0.05比2.64±0.06,2.58±0.02;bcl - 2 /β肌动蛋白:0.65±0.01和0.40±0.01,0.41±0.01;P62 /β-actin: 0.45±0.01 vs. 0.23±0.02,0.29±0.01;P < 0.05)。(2)动物实验:与Sham组比较,DOX组和DOX+NC组心肌纤维化面积百分比显著增加,左室射血分数(LVEF)和分数缩短(FS)显著降低。与DOX组和DOX+NC组比较,DOX+TERT组心肌纤维化面积百分比显著降低(%:2.33±0.06比3.76±0.07,3.87±0.06,P均< 0.05),LVEF和FS显著升高[LVEF(%): 67.00±1.14比54.60±1.57,53.40±2.18;FS(%): 38.60±0.51 vs. 30.60±1.10,30.00±0.71;P < 0.05]。结论:上调TERT表达可抑制dox诱导的心肌细胞自噬和凋亡,减轻dox诱导的小鼠心肌纤维化,改善心功能,从而减轻dox诱导的心脏毒性。
{"title":"[Study on the effects of telomerase reverse transcriptase in alleviating doxorubicin induced cardiotoxicity].","authors":"Qingqing Gu, Qianwe Chen, Yu Wang, Dabei Cai, Tingting Xiao, Qingjie Wang, Ling Sun","doi":"10.3760/cma.j.cn121430-20240711-00582","DOIUrl":"10.3760/cma.j.cn121430-20240711-00582","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the role of telomerase reverse transcriptase (TERT) in alleviating doxorubicin (DOX)-induced cardiotoxicity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;(1) Cell experiments: rat H9c2 cardiomyocytes were divided into control group (CON group), null adenovirus transfection group (NC group), TERT overexpression adenovirus transfection group (TERT group), DOX group (treated with 1 μmol/L DOX for 12 hours), DOX+NC group, and DOX+TERT group (null adenovirus or TERT overexpression adenovirus were transfected for 24 hours and then treated with 1 μmol/L DOX for 12 hours). The mRNA expression of TERT in cardiomyocytes was detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR). The level of mitochondrial membrane potential was detected by immunofluorescence. The expression levels of intracellular Bax, Bcl-2, microtubule-associated protein 1 light chain 3 (LC3) and p62 were detected by Western blotting. (2) Animal experiments: male C57BL/6 mice were randomly divided into a sham operation group (Sham group), DOX group (acute cardiotoxicity model was constructed by intraperitoneal injection of DOX 15 mg/kg), DOX+NC group and DOX+TERT group (modeled after transfection with airborne adenovirus or TERT overexpression adenovirus for 7 days). After 7 days of modeling, the area of myocardial fibrosis was detected by Sirius scarlet staining, and cardiac function was detected by echocardiography.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;(1) Cellular experiments: the mRNA expression level of TERT was significantly higher in the TERT group compared with the CON and NC groups. Compared with the CON group, the TERT mRNA expression level of cardiomyocytes in the DOX group and the DOX+NC group were significantly lower, the level of mitochondrial membrane potential was significantly lower, the protein expressions of Bax and LC3 were significantly increased, and the protein expressions of Bcl-2 and p62 were significantly decreased. No significant differences were found between the DOX group and DOX+NC group. Compared with the DOX group and DOX+NC group, the TERT mRNA expression level was increased in the DOX+TERT group (relative expression: 1.02±0.10 vs. 0.61±0.05, 0.54±0.03, both P &lt; 0.05), the level of mitochondrial membrane potential was significantly increased (1.14±0.05 vs. 0.96±0.01, 0.96±0.01, both P &lt; 0.05), the protein expressions of Bax and LC3 were significantly decreased, and the protein expressions of Bcl-2 and p62 were significantly increased (Bax/β-actin: 0.88±0.01 vs. 1.31±0.02, 1.26±0.01; LC3-II/I: 2.16±0.05 vs. 2.64±0.06, 2.58±0.02; Bcl-2/β-actin: 0.65±0.01 vs. 0.40±0.01, 0.41±0.01; p62/β-actin: 0.45±0.01 vs. 0.23±0.02, 0.29±0.01; all P &lt; 0.05). (2) Animal experiments: compared with the Sham group, the percentage of myocardial fibrosis area was significantly increased and left ventricular ejection fraction (LVEF) and fractional shortening (FS) were significantly decreased in the DOX group and DOX+NC grou","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"583-589"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Development, comparison and validation of clinical predictive models for brain injury after in-hospital post-cardiac arrest in critically ill patients]. [危重患者院内心脏骤停后脑损伤临床预测模型的建立、比较和验证]。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20240409-00322
Guowu Xu, Yanxiang Niu, Xin Chen, Wenjing Zhou, Abudou Halidan, Heng Jin, Jinxiang Wang
<p><strong>Objective: </strong>To develop and compare risk prediction models for in-hospital post-cardiac arrest brain injury (PCABI) in critically ill patients using nomograms and random forest algorithms, aiming to identify the optimal model for early identification of high-risk PCABI patients and providing evidence for precise treatment.</p><p><strong>Methods: </strong>A retrospective cohort study was used to collect the first-time in-hospital cardiac arrest (IHCA) patients admitted to the intensive care unit (ICU) from 2008 to 2019 in the Medical Information Mart for Intensive Care-IV (MIMIC-IV) as the study population, and the patients' age, gender, body mass, health insurance utilization, first vital signs and laboratory tests within 24 hours of ICU admission, mechanical ventilation, and critical care scores were extracted. Independent influencing factors of PCABI were identified through univariate and multivariate Logistic regression analyses. The included patients were randomly divided into a training cohort and an internal validation cohort in a 7:3 ratio, and the PCABI risk prediction model was constructed by the nomogram and random forest algorithm, respectively, and the model was evaluated by receiver operator characteristic curve (ROC curve), the calibration curve, and the decision curve analysis (DCA), and after the better model was selected, 179 patients admitted to Tianjin Medical University General Hospital as the external validation cohort for external evaluation were collected by using the same inclusion and exclusion criteria.</p><p><strong>Results: </strong>A total of 1 419 patients with without traumatic brain injury who had their first-time IHCA were enrolled, including 995 in the training cohort (including 176 PCABI and 819 non-PCABI) and 424 in the internal validation cohort (including 74 PCABI and 350 non-PCABI). Univariate and multivariate analysis showed that age, potassium, urea nitrogen, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation III (APACHE III), and mechanical ventilation were independent influences on the occurrence of PCABI in patients with IHCA (all P < 0.05). Combining the above variables, we constructed a nomogram model and a random forest model for comparison, and the results show that the nomogram model has better predictive efficacy than the random forest model [nomogram model: area under the ROC curve (AUC) of the training cohort = 0.776, with a 95% credible interval (95%CI) of 0.741-0.811; internal validation cohort AUC = 0.776, with a 95%CI of 0.718-0.833; random forest model: AUC = 0.720, with a 95%CI of 0.653-0.787], and they performed similarly in terms of calibration curves, but the nomogram performed better in terms of decision curve analysis (DCA); at the same time, the nomogram model was robust in terms of external validation cohort (external validation cohort AUC = 0.784, 95%CI was 0.692-0.876).</p><p><strong>Conclusions: </strong>A nomogram risk pr
目的:应用nomogram和random forest算法建立危重患者院内心搏停止后脑损伤(PCABI)的风险预测模型并进行比较,为早期识别PCABI高危患者提供最佳模型,为精准治疗提供依据。方法:采用回顾性队列研究方法,收集2008 - 2019年在重症监护医疗信息市场(MIMIC-IV)中入住重症监护病房(ICU)的首次院内心脏骤停(IHCA)患者作为研究人群,提取患者的年龄、性别、体重、健康保险使用情况、ICU入院24小时内首次生命体征和实验室检查、机械通气和重症监护评分。通过单因素和多因素Logistic回归分析,确定PCABI的独立影响因素。将纳入的患者按7:3的比例随机分为训练队列和内部验证队列,分别采用nomogram和random forest算法构建PCABI风险预测模型,并通过receiver operator characteristic curve (ROC曲线)、calibration curve(校准曲线)和decision curve analysis (DCA)对模型进行评价,选出较优模型后,采用相同的纳入标准和排除标准,收集天津医科大学总医院收治的179例患者作为外部验证队列进行外部评价。结果:共纳入1 419例首次进行IHCA的非外伤性脑损伤患者,其中培训组995例(其中PCABI组176例,非PCABI组819例),内部验证组424例(其中PCABI组74例,非PCABI组350例)。单因素和多因素分析显示,年龄、钾、尿素氮、顺序器官衰竭评估(SOFA)、急性生理和慢性健康评估III (APACHE III)、机械通气是IHCA患者PCABI发生的独立影响因素(均P < 0.05)。结合上述变量,我们构建了nomogram模型和random forest模型进行比较,结果显示nomogram模型比random forest模型具有更好的预测效果[nomogram模型:训练队列ROC曲线下面积(area under the ROC curve, AUC) = 0.776, 95%可信区间(95% ci)为0.741-0.811;内部验证队列AUC = 0.776, 95%CI为0.718-0.833;随机森林模型:AUC = 0.720, 95%CI为0.653-0.787],两者在校正曲线方面表现相似,但nomogram在决策曲线分析(decision curve analysis, DCA)方面表现更好;同时,在外部验证队列方面,nomogram模型具有稳健性(外部验证队列AUC = 0.784, 95%CI为0.692 ~ 0.876)。结论:成功构建了危重患者发生PCABI的nomogram风险预测模型,该模型优于随机森林模型,有助于临床医生早期识别危重患者发生PCABI的风险,为早期干预提供理论依据。
{"title":"[Development, comparison and validation of clinical predictive models for brain injury after in-hospital post-cardiac arrest in critically ill patients].","authors":"Guowu Xu, Yanxiang Niu, Xin Chen, Wenjing Zhou, Abudou Halidan, Heng Jin, Jinxiang Wang","doi":"10.3760/cma.j.cn121430-20240409-00322","DOIUrl":"10.3760/cma.j.cn121430-20240409-00322","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To develop and compare risk prediction models for in-hospital post-cardiac arrest brain injury (PCABI) in critically ill patients using nomograms and random forest algorithms, aiming to identify the optimal model for early identification of high-risk PCABI patients and providing evidence for precise treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective cohort study was used to collect the first-time in-hospital cardiac arrest (IHCA) patients admitted to the intensive care unit (ICU) from 2008 to 2019 in the Medical Information Mart for Intensive Care-IV (MIMIC-IV) as the study population, and the patients' age, gender, body mass, health insurance utilization, first vital signs and laboratory tests within 24 hours of ICU admission, mechanical ventilation, and critical care scores were extracted. Independent influencing factors of PCABI were identified through univariate and multivariate Logistic regression analyses. The included patients were randomly divided into a training cohort and an internal validation cohort in a 7:3 ratio, and the PCABI risk prediction model was constructed by the nomogram and random forest algorithm, respectively, and the model was evaluated by receiver operator characteristic curve (ROC curve), the calibration curve, and the decision curve analysis (DCA), and after the better model was selected, 179 patients admitted to Tianjin Medical University General Hospital as the external validation cohort for external evaluation were collected by using the same inclusion and exclusion criteria.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 1 419 patients with without traumatic brain injury who had their first-time IHCA were enrolled, including 995 in the training cohort (including 176 PCABI and 819 non-PCABI) and 424 in the internal validation cohort (including 74 PCABI and 350 non-PCABI). Univariate and multivariate analysis showed that age, potassium, urea nitrogen, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation III (APACHE III), and mechanical ventilation were independent influences on the occurrence of PCABI in patients with IHCA (all P &lt; 0.05). Combining the above variables, we constructed a nomogram model and a random forest model for comparison, and the results show that the nomogram model has better predictive efficacy than the random forest model [nomogram model: area under the ROC curve (AUC) of the training cohort = 0.776, with a 95% credible interval (95%CI) of 0.741-0.811; internal validation cohort AUC = 0.776, with a 95%CI of 0.718-0.833; random forest model: AUC = 0.720, with a 95%CI of 0.653-0.787], and they performed similarly in terms of calibration curves, but the nomogram performed better in terms of decision curve analysis (DCA); at the same time, the nomogram model was robust in terms of external validation cohort (external validation cohort AUC = 0.784, 95%CI was 0.692-0.876).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;A nomogram risk pr","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"560-567"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ineffective triggering and double triggering in patients with acute brain injury undergoing invasive mechanical ventilation]. 急性脑损伤有创机械通气患者的无效触发和双重触发。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20240625-00539
Xuying Luo, Xuan He, Jianfang Zhou, Yimin Zhou, Guangqiang Chen, Hongliang Li, Yanlin Yang, Linlin Zhang, Jianxin Zhou

Objective: To investigate the frequency and related factors of ineffective triggering (IT) and double triggering (DT) in patients with acute brain injury undergoing invasive mechanical ventilation.

Methods: A retrospective cohort study was conducted using data from a single-center observational trial. Patients with acute brain injury [traumatic brain injury, stroke, and post-craniotomy for brain tumors] undergoing mechanical ventilation in the intensive care unit (ICU) of Beijing Tiantan Hospital, Capital Medical University between June 2017 and July 2019 were retrospectively analyzed. Demographic and clinical data were collected. Respiratory parameters and waveforms during the first 3 days of mechanical ventilation were recorded, with 15-minute waveform segments collected 4 times daily. Airway occlusion pressure (P0.1) was measured via end-expiratory hold at the end of each recording. IT and DT were identified based on airway pressure, flow, and esophageal pressure waveforms, and the ineffective triggering index (ITI) and DT incidence were calculated. Multivariate Logistic regression was used to identify factors associated with IT and DT.

Results: A total of 94 patients with acute brain injury were ultimately enrolled, including 19 cases of traumatic brain injury (20.2%), 39 cases of stroke (41.5%), and 36 cases of post-craniotomy for brain tumor (38.3%). Supratentorial injury was observed in 49 patients (52.1%), while infratentorial injury was identified in 45 patients (47.9%). A total of 94 patients with 1 018 datasets were analyzed; 684 (67.2%) datasets were on pressure support ventilation (PSV), and 334 (32.8%) were on mandatory ventilation. IT was detected in 810 (79.6%) datasets, with a median incidence of 2.1% (0.3%, 12.0%). Datasets demonstrating IT were characterized by lower P0.1, higher tidal volume (VT), reduced respiratory rate (RR), and decreased minute ventilation (MV) compared to those without IT. The proportion of datasets exhibiting IT was higher during PSV than in mandatory ventilation [83.8% (573/684) vs. 71.0% (237/334), P < 0.05], while, the prevalence of ITI ≥ 10% was lower [23.8% (163/684) vs. 33.5% (112/334), P < 0.05]. DT was detected in 305 datasets (30%), with a median incidence of 0.6% (0.4%, 1.3%). Datasets exhibiting DT were characterized by higher VT, reduced RR, and lower pressure support levels. The incidence of DT was lower in PSV compared to mandatory ventilation modes [0% (0%, 0.3%) vs. 0% (0%, 0.5%), P < 0.05]. The post-craniotomy for brain tumors group exhibited higher ITI, lower RR, reduced MV, and a greater proportion of infratentorial lesions, compared to the TBI group. The infratentorial lesion group demonstrated higher ITI and incidence of DT compared to the supratentorial lesion group [ITI: 3.1% (0.7%, 17.8%) vs. 1.5% (0%, 8.3%), incidence of DT: 0% (0%, 0.5%) vs. 0% (0%, 0%), both P < 0.05]. After adjusting for co

目的:探讨急性脑损伤行有创机械通气患者发生无效触发(IT)和双重触发(DT)的频率及相关因素。方法:采用单中心观察性试验资料进行回顾性队列研究。回顾性分析2017年6月至2019年7月首都医科大学附属北京天坛医院重症监护病房(ICU)机械通气的急性脑损伤[外伤性脑损伤、脑卒中及颅脑肿瘤开颅术后]患者。收集了人口统计学和临床数据。记录机械通气前3 d的呼吸参数和波形,每天采集4次15分钟波形段。在每次记录结束时通过呼气末保持测量气道闭塞压(P0.1)。根据气道压力、血流和食管压力波形识别IT和DT,计算无效触发指数(ITI)和DT发生率。采用多变量Logistic回归来确定与IT和DT相关的因素。结果:最终纳入94例急性脑损伤患者,其中外伤性脑损伤19例(20.2%),脑卒中39例(41.5%),开颅后脑肿瘤36例(38.3%)。幕上损伤49例(52.1%),幕下损伤45例(47.9%)。共分析94例患者1 018个数据集;684例(67.2%)数据集采用压力支持通气(PSV), 334例(32.8%)数据集采用强制通气。810例(79.6%)数据集检测到IT,中位发病率为2.1%(0.3%,12.0%)。与没有IT的数据集相比,显示IT的数据集具有较低的P0.1,较高的潮气量(VT),降低的呼吸速率(RR)和降低的分钟通气量(MV)。PSV期间显示IT的数据集比例高于强制通气期间[83.8%(573/684)比71.0% (237/334),P < 0.05], ITI≥10%的患病率较低[23.8%(163/684)比33.5% (112/334),P < 0.05]。305个数据集(30%)检测到DT,中位发病率为0.6%(0.4%,1.3%)。显示DT的数据集具有更高的VT、更低的RR和更低的压力支持水平。与强制通气模式相比,PSV患者DT的发生率较低[0%(0%,0.3%)比0% (0%,0.5%),P < 0.05]。与TBI组相比,脑肿瘤开颅后组表现出更高的ITI、更低的RR、更低的MV和更大比例的幕下病变。幕下病变组ITI和DT发生率均高于幕上病变组[ITI: 3.1%(0.7%, 17.8%)比1.5% (0%,8.3%),DT发生率:0%(0%,0.5%)比0% (0%,0%),P均< 0.05]。通过多因素logistic回归分析调整混杂因素后,幕下病变[优势比(OR) = 2.029, 95%可信区间(95% ci)为1.465 ~ 2.811,P < 0.001]、低P0.1 (OR = 0.714, 95% ci为0.616 ~ 0.827,P < 0.001)和强制通气(OR = 1.613, 95% ci为1.164 ~ 2.236,P = 0.004)与IT独立相关。此外,幕下病变(OR = 1.618, 95%CI为1.213 ~ 2.157,P = 0.001)、潮气量大(OR = 1.222, 95%CI为1.137 ~ 1.314,P < 0.001)、低压力支持水平(OR = 0.876, 95%CI为0.829 ~ 0.925,P < 0.001)、强制通气(OR = 2.750, 95%CI为1.983 ~ 3.814,P < 0.001)与DT独立相关。结论:IT和DT在急性脑损伤患者中较为常见。幕下病变和强制通气与IT和DT独立相关。
{"title":"[Ineffective triggering and double triggering in patients with acute brain injury undergoing invasive mechanical ventilation].","authors":"Xuying Luo, Xuan He, Jianfang Zhou, Yimin Zhou, Guangqiang Chen, Hongliang Li, Yanlin Yang, Linlin Zhang, Jianxin Zhou","doi":"10.3760/cma.j.cn121430-20240625-00539","DOIUrl":"10.3760/cma.j.cn121430-20240625-00539","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the frequency and related factors of ineffective triggering (IT) and double triggering (DT) in patients with acute brain injury undergoing invasive mechanical ventilation.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using data from a single-center observational trial. Patients with acute brain injury [traumatic brain injury, stroke, and post-craniotomy for brain tumors] undergoing mechanical ventilation in the intensive care unit (ICU) of Beijing Tiantan Hospital, Capital Medical University between June 2017 and July 2019 were retrospectively analyzed. Demographic and clinical data were collected. Respiratory parameters and waveforms during the first 3 days of mechanical ventilation were recorded, with 15-minute waveform segments collected 4 times daily. Airway occlusion pressure (P<sub>0.1</sub>) was measured via end-expiratory hold at the end of each recording. IT and DT were identified based on airway pressure, flow, and esophageal pressure waveforms, and the ineffective triggering index (ITI) and DT incidence were calculated. Multivariate Logistic regression was used to identify factors associated with IT and DT.</p><p><strong>Results: </strong>A total of 94 patients with acute brain injury were ultimately enrolled, including 19 cases of traumatic brain injury (20.2%), 39 cases of stroke (41.5%), and 36 cases of post-craniotomy for brain tumor (38.3%). Supratentorial injury was observed in 49 patients (52.1%), while infratentorial injury was identified in 45 patients (47.9%). A total of 94 patients with 1 018 datasets were analyzed; 684 (67.2%) datasets were on pressure support ventilation (PSV), and 334 (32.8%) were on mandatory ventilation. IT was detected in 810 (79.6%) datasets, with a median incidence of 2.1% (0.3%, 12.0%). Datasets demonstrating IT were characterized by lower P<sub>0.1</sub>, higher tidal volume (VT), reduced respiratory rate (RR), and decreased minute ventilation (MV) compared to those without IT. The proportion of datasets exhibiting IT was higher during PSV than in mandatory ventilation [83.8% (573/684) vs. 71.0% (237/334), P < 0.05], while, the prevalence of ITI ≥ 10% was lower [23.8% (163/684) vs. 33.5% (112/334), P < 0.05]. DT was detected in 305 datasets (30%), with a median incidence of 0.6% (0.4%, 1.3%). Datasets exhibiting DT were characterized by higher VT, reduced RR, and lower pressure support levels. The incidence of DT was lower in PSV compared to mandatory ventilation modes [0% (0%, 0.3%) vs. 0% (0%, 0.5%), P < 0.05]. The post-craniotomy for brain tumors group exhibited higher ITI, lower RR, reduced MV, and a greater proportion of infratentorial lesions, compared to the TBI group. The infratentorial lesion group demonstrated higher ITI and incidence of DT compared to the supratentorial lesion group [ITI: 3.1% (0.7%, 17.8%) vs. 1.5% (0%, 8.3%), incidence of DT: 0% (0%, 0.5%) vs. 0% (0%, 0%), both P < 0.05]. After adjusting for co","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"555-559"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interaction of α-amylase and inflammatory response in patients with ventilator-associated pneumonia and their prognostic value]. [呼吸机相关性肺炎患者α-淀粉酶与炎症反应的相互作用及其预后价值]。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20240409-00321
Yexing Liu, Yanzeng Peng, Yuding Hu, Chao Liu

Objective: To investigate the interaction between α-amylase (α-AMS) and inflammatory response in patients with ventilator-associated pneumonia (VAP) and their predictive value for prognosis.

Methods: A prospective cohort study was conducted. Patients with mechanical ventilation who were treated in the intensive care unit (ICU) of the Second Hospital of Hebei Medical University from June 2020 to June 2023 were enrolled, and the patients were divided into VAP group and non-VAP group according to whether VAP occurred. VAP patients were stratified into mild [acute physiology and chronic health evaluation II (APACHE II) < 10 scores], moderate (APACHE II were 10-20 scores), and severe (APACHE II > 20 scores) groups based on the APACHE II. All patients were followed up for 28 days. In addition, healthy subjects who underwent health examination in our hospital at the same time were selected as the healthy control group. Baseline data including gender, age, mechanical ventilation mode, mechanical ventilation time, underlying diseases, drug use, and laboratory test indicators were collected. The serum levels of α-AMS, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP) and other inflammatory factors were analyzed and compared. Pearson correlation analysis was performed to analyze the correlation between serum α-AMS and inflammatory factors. Logistic regression was used to analyze the influencing factors of poor prognosis in patients with VAP. The receiver operator characteristic curve (ROC curve) was plotted to evaluate the predictive value of α-AMS on the poor prognosis of patients with VAP.

Results: A total of 100 mechanically ventilated patients were enrolled, including 60 cases in the VAP group and 40 cases in the non-VAP group. Among the patients with VAP, there were 24 cases in the mild group, 20 cases in the moderate group, and 16 cases in the severe group. A total of 44 patients survived at 28 days, while 16 died. Additionally, 100 healthy individuals were included as the healthy control group. Serum levels of α-AMS, IL-6, TNF-α and CRP in the VAP group were significantly higher than those in the non-VAP group and the healthy control group, while the levels of α-AMS, IL-6, TNF-α and CRP in the non-VAP group were significantly higher than those in the healthy control group. There were statistically significant differences in serum α-AMS, IL-6, TNF-α, CRP levels and APACHE II scores among VAP patients with different disease severities, and the levels of the above indicators in the severe group were significantly higher than those in the moderate group and mild group, and the levels of the above indicators in the moderate VAP group were significantly higher than those in the mild group. Pearson correlation analysis showed that serum α-AMS was positively correlated with IL-6, TNF-α, CRP, and APACHE II scores (r values were 0.404, 0.392 and 0.493, 0.493, all P

目的:探讨α-淀粉酶(α-AMS)与呼吸机相关性肺炎(VAP)患者炎症反应的相互作用及其对预后的预测价值。方法:采用前瞻性队列研究。选取2020年6月至2023年6月在河北医科大学第二医院重症监护病房(ICU)接受机械通气治疗的患者,根据是否发生VAP分为VAP组和非VAP组。根据APACHE评分将VAP患者分为轻度(急性生理和慢性健康评估II (APACHE II) < 10分)、中度(APACHE II为10-20分)和重度(APACHE II bb0 -20分)组。所有患者随访28 d。另外,选取同期在我院进行健康检查的健康受试者作为健康对照组。基线资料包括性别、年龄、机械通气方式、机械通气时间、基础疾病、用药情况、实验室检测指标。分析比较两组血清α-AMS、白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)、c反应蛋白(CRP)等炎症因子水平。采用Pearson相关分析分析血清α-AMS与炎症因子的相关性。采用Logistic回归分析VAP患者预后不良的影响因素。绘制受试者操作者特征曲线(ROC曲线),评价α-AMS对VAP患者不良预后的预测价值。结果:共纳入100例机械通气患者,其中VAP组60例,非VAP组40例。VAP患者中,轻度组24例,中度组20例,重度组16例。28天存活44例,死亡16例。另外,选取100名健康个体作为健康对照组。VAP组血清α-AMS、IL-6、TNF-α和CRP水平均显著高于非VAP组和健康对照组,而非VAP组血清α-AMS、IL-6、TNF-α和CRP水平均显著高于健康对照组。不同病情严重程度VAP患者血清α-AMS、IL-6、TNF-α、CRP水平及APACHEⅱ评分差异均有统计学意义,且重症组上述指标水平均显著高于中度组和轻度组,中度VAP组上述指标水平均显著高于轻度组。Pearson相关分析显示,血清α-AMS与IL-6、TNF-α、CRP、APACHEⅱ评分呈正相关(r值分别为0.404、0.392和0.493、0.493,P均< 0.01)。单因素分析显示,年龄、机械通气、糖尿病、通气时间、通气体位、预防使用抗菌药物、血清α-AMS、IL-6、TNF-α、CRP、APACHEⅱ评分与VAP患者预后相关(均P < 0.05)。多因素Logistic回归分析确定年龄[优势比(OR) = 1.340, 95%可信区间(95% ci)为1.119 ~ 1.605]、气管吻合(OR = 3.050, 95% ci为1.016 ~ 9.157)、糖尿病(OR = 1.379, 95% ci为1.102 ~ 1.724)、通气时间≥7天(OR = 2.557, 95% ci为1.163 ~ 5.623)、血清α-AMS (OR = 1.428, 95% ci为1.098 ~ 1.856)、IL-6 (OR = 1.543, 95% ci为1.005 ~ 2.371)、TNF-α (OR = 2.228, 95% ci为1.107 ~ 4.485)、CRP (OR = 1.252, 95% ci为1.131 ~ 1.387)、APACHE II评分(OR = 1.422, 95%CI为1.033 ~ 1.957)是VAP患者28天预后的独立影响因素(均P < 0.05)。ROC曲线分析显示血清α-AMS、IL-6、TNF-α、CRP对VAP患者的预后有显著的预测作用。α-AMS的最佳临界值敏感性为81.3%,特异性为75.0%,ROC曲线下面积(AUC)为0.791,显著高于炎症标志物IL-6、TNF-α和CRP (P < 0.05)。综合参数的诊断效能显著优于单项参数(P < 0.05),综合参数的诊断效能最高,AUC为0.868 (95%CI为0.798 ~ 0.938),敏感性为87.5%,特异性为79.5%。结论:机械通气患者VAP可导致外周血α-AMS及炎症因子水平升高,严重VAP患者α-AMS与炎症标志物存在相互作用。这些标志物与疾病的严重程度和预后密切相关,对预测患者预后有重要意义。
{"title":"[Interaction of α-amylase and inflammatory response in patients with ventilator-associated pneumonia and their prognostic value].","authors":"Yexing Liu, Yanzeng Peng, Yuding Hu, Chao Liu","doi":"10.3760/cma.j.cn121430-20240409-00321","DOIUrl":"10.3760/cma.j.cn121430-20240409-00321","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the interaction between α-amylase (α-AMS) and inflammatory response in patients with ventilator-associated pneumonia (VAP) and their predictive value for prognosis.</p><p><strong>Methods: </strong>A prospective cohort study was conducted. Patients with mechanical ventilation who were treated in the intensive care unit (ICU) of the Second Hospital of Hebei Medical University from June 2020 to June 2023 were enrolled, and the patients were divided into VAP group and non-VAP group according to whether VAP occurred. VAP patients were stratified into mild [acute physiology and chronic health evaluation II (APACHE II) < 10 scores], moderate (APACHE II were 10-20 scores), and severe (APACHE II > 20 scores) groups based on the APACHE II. All patients were followed up for 28 days. In addition, healthy subjects who underwent health examination in our hospital at the same time were selected as the healthy control group. Baseline data including gender, age, mechanical ventilation mode, mechanical ventilation time, underlying diseases, drug use, and laboratory test indicators were collected. The serum levels of α-AMS, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP) and other inflammatory factors were analyzed and compared. Pearson correlation analysis was performed to analyze the correlation between serum α-AMS and inflammatory factors. Logistic regression was used to analyze the influencing factors of poor prognosis in patients with VAP. The receiver operator characteristic curve (ROC curve) was plotted to evaluate the predictive value of α-AMS on the poor prognosis of patients with VAP.</p><p><strong>Results: </strong>A total of 100 mechanically ventilated patients were enrolled, including 60 cases in the VAP group and 40 cases in the non-VAP group. Among the patients with VAP, there were 24 cases in the mild group, 20 cases in the moderate group, and 16 cases in the severe group. A total of 44 patients survived at 28 days, while 16 died. Additionally, 100 healthy individuals were included as the healthy control group. Serum levels of α-AMS, IL-6, TNF-α and CRP in the VAP group were significantly higher than those in the non-VAP group and the healthy control group, while the levels of α-AMS, IL-6, TNF-α and CRP in the non-VAP group were significantly higher than those in the healthy control group. There were statistically significant differences in serum α-AMS, IL-6, TNF-α, CRP levels and APACHE II scores among VAP patients with different disease severities, and the levels of the above indicators in the severe group were significantly higher than those in the moderate group and mild group, and the levels of the above indicators in the moderate VAP group were significantly higher than those in the mild group. Pearson correlation analysis showed that serum α-AMS was positively correlated with IL-6, TNF-α, CRP, and APACHE II scores (r values were 0.404, 0.392 and 0.493, 0.493, all P ","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"535-541"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Meta-analysis of hydrocortisone in the treatment of severe community-acquired pneumonia]. 氢化可的松治疗重症社区获得性肺炎的meta分析。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20230710-00500
Xue Gu, Penglei Yang, Lina Yu, Jun Yuan, Zhou Yuan, Xiaoli Zhang, Lianxin Chen, Ying Zhang, Jikuan Hu, Yu Huang, Qihong Chen

Objective: To explore whether hydrocortisone can improve the prognosis of patients with severe community-acquired pneumonia (sCAP) by Meta-analysis.

Methods: Randomized controlled trial (RCT) on hydrocortisone in the treatment of sCAP were extracted from the database including PubMed, Cochrane library, Web of Science, and Embase, and the search time was up to April 29, 2023. The patients in the standard treatment group received standard treatment such as antibiotics and supportive care, while those in the hydrocortisone group received hydrocortisone treatment on the basis of standard treatment. Meta-analysis was used to compare the mortality, duration of mechanical ventilation, mechanical ventilation rate and incidence of adverse reactions (hyperglycemia, gastrointestinal bleeding, secondary infection) between the two groups. The risk of literature bias was assessed. The studies that might have publication bias were corrected by the subtraction and complementation method. At the same time, trial sequential analysis (TSA) was conducted.

Results: A total of 5 RCTs involving 1 031 patients were finally enrolled, including 494 patients in the standard treatment group and 537 patients in the hydrocortisone group. Among the 5 studies, the research site of 2 studies was in the mixed ward. Considering the inclusion characteristics of the study population, there was doubt whether its research object was sCAP patients, which might have a certain impact on the results and introduce potential bias. Meta-analysis showed that the mortality in the hydrocortisone group was significantly lower than that in the standard treatment group [6.0% vs. 14.0%; odds ratio (OR) = 0.38, 95% confidence interval (95%CI) was 0.25-0.59, P < 0.01; I2 = 9%]. The studies that were asymmetric were corrected by the reduction and supplementation method. Even after filling the missing studies, hydrocortisone could still reduce the death risk of the patient (OR = 0.49, 95%CI was 0.32-0.73, P < 0.01; I2 = 31%). TSA showed that the average mortality of the standard treatment group was about 14.0%, and that of the hydrocortisone group was about 6.0%, with a relative risk reduction (RRR) = 57%. The calculated sample size was 699 cases, and the actual sample size was 1 031 cases. The actual sample size exceeded the required sample size, and the Z-curve crossed the O'Brien-Fleming boundary and the curve corresponding to P = 0.05, it meant that hydrocortisone could effectively reduce the mortality of sCAP. Compared with the standard treatment group, no statistical difference in the duration of mechanical ventilation was found in the hydrocortisone group [mean difference (MD) = -3.26, 95%CI was -6.72-0.21, P = 0.07; I2 = 0%], but the 8-day mechanical ventilation rate was significantly lowered (19.5% vs. 55.4%; OR = 0.24, 95%CI was 0.12-0.45, P < 0.01; I2 = 0%), and also no significantly

目的:通过meta分析,探讨氢化可的松是否能改善重症社区获得性肺炎(sCAP)患者的预后。方法:从PubMed、Cochrane图书馆、Web of Science、Embase等数据库中提取氢化可的松治疗sCAP的随机对照试验(RCT),检索时间截止到2023年4月29日。标准治疗组患者给予抗生素、支持治疗等标准治疗,氢化可的松组患者在标准治疗的基础上给予氢化可的松治疗。采用meta分析比较两组患者的死亡率、机械通气时间、机械通气率及不良反应(高血糖、胃肠道出血、继发感染)发生率。评估文献偏倚的风险。对可能存在发表偏倚的研究采用减法和补充法进行校正。同时进行试验序列分析(TSA)。结果:最终纳入5项rct,共纳入1 031例患者,其中标准治疗组494例,氢化可的松组537例。5项研究中,2项研究的研究地点在混合病房。考虑到研究人群的纳入特点,其研究对象是否为sCAP患者存在疑问,这可能会对结果产生一定影响,并引入潜在的偏倚。荟萃分析显示,氢化可的松组的死亡率显著低于标准治疗组[6.0% vs. 14.0%;优势比(OR) = 0.38, 95%可信区间(95% ci)为0.25 ~ 0.59,P < 0.01;I2 = 9%]。不对称的研究通过还原和补充法进行校正。即使填补了缺失的研究,氢化可的松仍然可以降低患者的死亡风险(OR = 0.49, 95%CI为0.32 ~ 0.73,P < 0.01; I2 = 31%)。TSA显示,标准治疗组的平均死亡率约为14.0%,氢化可的松组的平均死亡率约为6.0%,相对风险降低率(RRR)为57%。计算样本量为699例,实际样本量为1 031例。实际样本量超过要求的样本量,且z曲线跨越O'Brien-Fleming边界,曲线对应P = 0.05,说明氢化可的松可以有效降低sCAP的死亡率。与标准治疗组比较,氢化可的松组机械通气时间无统计学差异[MD = -3.26, 95%CI为-6.72 ~ 0.21,P = 0.07;I2 = 0%),但密集机械通气率明显降低(19.5%比55.4%;或者= 0.24,95%可信区间0.12 - -0.45,P < 0.01; I2 = 0%),也没有发现显著差异在高血糖的发生率(54.3%比44.6%,或= 1.26,95%可信区间0.56 - -2.84,P = 0.58; I2 = 61%),消化道出血(2.5%比3.6%;或者= 0.70,95%可信区间0.34 - -1.46,P = 0.34; I2 = 0%)和继发性感染(9.2%比11.5%;或者= 0.46,95%可信区间0.06 - -3.35,P = 0.45; I2 = 53%)。结论:氢化可的松可降低sCAP患者的死亡率,降低其机械通气需求,且不增加高血糖、胃肠道出血或继发感染的风险。
{"title":"[Meta-analysis of hydrocortisone in the treatment of severe community-acquired pneumonia].","authors":"Xue Gu, Penglei Yang, Lina Yu, Jun Yuan, Zhou Yuan, Xiaoli Zhang, Lianxin Chen, Ying Zhang, Jikuan Hu, Yu Huang, Qihong Chen","doi":"10.3760/cma.j.cn121430-20230710-00500","DOIUrl":"10.3760/cma.j.cn121430-20230710-00500","url":null,"abstract":"<p><strong>Objective: </strong>To explore whether hydrocortisone can improve the prognosis of patients with severe community-acquired pneumonia (sCAP) by Meta-analysis.</p><p><strong>Methods: </strong>Randomized controlled trial (RCT) on hydrocortisone in the treatment of sCAP were extracted from the database including PubMed, Cochrane library, Web of Science, and Embase, and the search time was up to April 29, 2023. The patients in the standard treatment group received standard treatment such as antibiotics and supportive care, while those in the hydrocortisone group received hydrocortisone treatment on the basis of standard treatment. Meta-analysis was used to compare the mortality, duration of mechanical ventilation, mechanical ventilation rate and incidence of adverse reactions (hyperglycemia, gastrointestinal bleeding, secondary infection) between the two groups. The risk of literature bias was assessed. The studies that might have publication bias were corrected by the subtraction and complementation method. At the same time, trial sequential analysis (TSA) was conducted.</p><p><strong>Results: </strong>A total of 5 RCTs involving 1 031 patients were finally enrolled, including 494 patients in the standard treatment group and 537 patients in the hydrocortisone group. Among the 5 studies, the research site of 2 studies was in the mixed ward. Considering the inclusion characteristics of the study population, there was doubt whether its research object was sCAP patients, which might have a certain impact on the results and introduce potential bias. Meta-analysis showed that the mortality in the hydrocortisone group was significantly lower than that in the standard treatment group [6.0% vs. 14.0%; odds ratio (OR) = 0.38, 95% confidence interval (95%CI) was 0.25-0.59, P < 0.01; I<sup>2</sup> = 9%]. The studies that were asymmetric were corrected by the reduction and supplementation method. Even after filling the missing studies, hydrocortisone could still reduce the death risk of the patient (OR = 0.49, 95%CI was 0.32-0.73, P < 0.01; I<sup>2</sup> = 31%). TSA showed that the average mortality of the standard treatment group was about 14.0%, and that of the hydrocortisone group was about 6.0%, with a relative risk reduction (RRR) = 57%. The calculated sample size was 699 cases, and the actual sample size was 1 031 cases. The actual sample size exceeded the required sample size, and the Z-curve crossed the O'Brien-Fleming boundary and the curve corresponding to P = 0.05, it meant that hydrocortisone could effectively reduce the mortality of sCAP. Compared with the standard treatment group, no statistical difference in the duration of mechanical ventilation was found in the hydrocortisone group [mean difference (MD) = -3.26, 95%CI was -6.72-0.21, P = 0.07; I<sup>2</sup> = 0%], but the 8-day mechanical ventilation rate was significantly lowered (19.5% vs. 55.4%; OR = 0.24, 95%CI was 0.12-0.45, P < 0.01; I<sup>2</sup> = 0%), and also no significantly","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"542-548"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the effect and safety of autologous blood reinfusion during venous-arterial extracorporeal membrane oxygenation weaning under controlled rotational speed]. [控制转速下静脉-动脉体外膜氧合脱机自体血液回输的效果及安全性分析]。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20250117-00066
Zhijing Xu, Yu'an Geng, Congmei Wang, Lu Qi, Yangang Shi, Zishu Xu, Linkai Huang, Qian Xu, Ruifang Liu

Objective: To investigate the efficacy and safety of autologous blood transfusion during weaning from venous-arterial extracorporeal membrane oxygenation (VA-ECMO) under controlled rotational speed.

Methods: A retrospective study was conducted, selecting patients who underwent extracorporeal membrane oxygenation (ECMO) and successfully weaned at the emergency and critical care medicine center of Henan Provincial Third People's Hospital from January 2023 to May 2024. General data including gender, age, body mass index (BMI), European system for cardiac operative risk evaluation (EuroScore), and disease types were collected. Vital signs at weaning [heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), and peripheral oxygen saturation], parameters before and after weaning [B-type natriuretic peptide (BNP), hemoglobin (Hb), partial pressure of arterial oxygen (PaO2), partial pressure of arterial carbon dioxide (PaCO2), arterial lactate, central venous pressure (CVP), inferior vena cava collapsibility index, left ventricular ejection fraction (LVEF), and right heart load], post-weaning inflammatory markers at 1-day and 3-day [body temperature, white blood cell count (WBC), neutrophil percentage (NEU%), C-reactive protein (CRP), procalcitonin (PCT), interleukin-10 (IL-10)], as well as complications (infection, thrombosis, renal failure, gastrointestinal bleeding) and post-weaning blood return status were recorded. Patients were divided into an observation group (with post-weaning blood return) and a control group (without post-weaning blood return) based on the presence of blood return after weaning. The changes in the aforementioned parameters were compared between the two groups.

Results: A total of 62 patients were included, with 31 cases in each group. No statistically significant differences were observed between the two groups in baseline characteristics including gender, age, BMI, and EuroScore. At weaning, the observation group exhibited relatively stable vital signs, with no significant differences in heart rate, SBP, DBP, or peripheral oxygen saturation compared to the control group. After weaning, the observation group showed significantly lower levels of BNP, PaCO2, arterial lactate, CVP, and right heart load compared to pre-weaning values [BNP (ng/L): 2 325.96±78.51 vs. 4 878.48±185.47, PaCO2 (mmHg, 1 mmHg≈0.133 kPa): 35.23±3.25 vs. 40.75±4.41, arterial lactate (mmol/L): 2.43±0.61 vs. 6.19±1.31, CVP (cmH2O, 1 cmH2O≈0.098 kPa): 8.32±0.97 vs. 15.34±1.74, right heart load: 13.24±0.97 vs. 15.69±1.31, all P < 0.05], while Hb, PaO2, inferior vena cava collapsibility index, and LVEF were significantly higher than pre-weaning values [Hb (g/L): 104.42±9.78 vs. 96.74±6.39, PaO2 (mmHg): 94.12±7.78 vs. 75.51±4.39, inferior vena cava collapsibility (%): 28±7 vs. 17±3, LVEF (%): 62

目的:探讨控制转速下静脉-动脉体外膜氧合(VA-ECMO)脱机过程中自体输血的有效性和安全性。方法:选取2023年1月至2024年5月在河南省第三人民医院急危重症医学中心行体外膜氧合(ECMO)并成功脱机的患者进行回顾性研究。一般资料包括性别、年龄、体重指数(BMI)、欧洲心脏手术风险评估系统(EuroScore)、疾病类型等。脱机时生命体征[心率、收缩压(SBP)、舒张压(DBP)、外周氧饱和度],脱机前后参数[b型利钠肽(BNP)、血红蛋白(Hb)、动脉氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、动脉乳酸、中心静脉压(CVP)、下腔静脉湿陷性指数、左室射血分数(LVEF)、右心负荷],记录断奶后第1天和第3天的炎症指标[体温、白细胞计数(WBC)、中性粒细胞百分比(NEU%)、c反应蛋白(CRP)、降钙素原(PCT)、白细胞介素-10 (IL-10)],以及并发症(感染、血栓形成、肾功能衰竭、胃肠道出血)和断奶后血液返回情况。根据断奶后是否有血液回流,将患者分为观察组(有断奶后血液回流)和对照组(无断奶后血液回流)。比较两组患者上述参数的变化情况。结果:共纳入62例患者,每组31例。两组在性别、年龄、BMI和EuroScore等基线特征方面无统计学差异。在脱机时,观察组表现出相对稳定的生命体征,与对照组相比,心率、收缩压、舒张压或外周氧饱和度无显著差异。断奶后,观察组患者BNP、PaCO2、动脉乳酸、CVP、右心负荷水平均较断奶前显著降低[BNP (ng/L): 2 325.96±78.51 vs. 4 878.48±185.47,PaCO2 (mmHg, 1 mmHg≈0.133 kPa): 35.23±3.25 vs. 40.75±4.41,动脉乳酸(mmol/L): 2.43±0.61 vs. 6.19±1.31,CVP (cmH2O, 1 cmH2O≈0.098 kPa): 8.32±0.97 vs. 15.34±1.74,右心负荷:Hb、PaO2、下腔静脉湿陷性指数、LVEF均显著高于断奶前[Hb (g/L): 104.42±9.78比96.74±6.39,PaO2 (mmHg): 94.12±7.78比75.51±4.39,下腔静脉湿陷性(%):28±7比17±3,LVEF(%): 62.41±6.49比45.30±4.51,均P < 0.05]。观察组与对照组在这些参数上均无统计学差异。断奶后3 d,观察组患者体温、WBC、NEU%、CRP、PCT、IL-10水平均明显低于断奶后1 d[体温(℃):36.83±1.15比37.94±1.41,WBC (×109/L): 7.82±0.96比14.34±2.15,NEU%: 0.71±0.05比0.80±0.07;CRP (mg/L): 4.34±0.78 vs. 8.94±1.21,PCT (μg/L): 0.11±0.02 vs. 0.26±0.05,IL-10 (ng/L): 8.93±1.52 vs. 13.51±2.17,P均< 0.05,与对照组比较差异无统计学意义。两组患者感染、血栓形成、肾功能衰竭、消化道出血等并发症发生率无统计学差异。结论:控制转速下VA-ECMO脱机时自体血回输安全有效,不增加感染和血栓形成风险。
{"title":"[Analysis of the effect and safety of autologous blood reinfusion during venous-arterial extracorporeal membrane oxygenation weaning under controlled rotational speed].","authors":"Zhijing Xu, Yu'an Geng, Congmei Wang, Lu Qi, Yangang Shi, Zishu Xu, Linkai Huang, Qian Xu, Ruifang Liu","doi":"10.3760/cma.j.cn121430-20250117-00066","DOIUrl":"10.3760/cma.j.cn121430-20250117-00066","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the efficacy and safety of autologous blood transfusion during weaning from venous-arterial extracorporeal membrane oxygenation (VA-ECMO) under controlled rotational speed.</p><p><strong>Methods: </strong>A retrospective study was conducted, selecting patients who underwent extracorporeal membrane oxygenation (ECMO) and successfully weaned at the emergency and critical care medicine center of Henan Provincial Third People's Hospital from January 2023 to May 2024. General data including gender, age, body mass index (BMI), European system for cardiac operative risk evaluation (EuroScore), and disease types were collected. Vital signs at weaning [heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), and peripheral oxygen saturation], parameters before and after weaning [B-type natriuretic peptide (BNP), hemoglobin (Hb), partial pressure of arterial oxygen (PaO<sub>2</sub>), partial pressure of arterial carbon dioxide (PaCO<sub>2</sub>), arterial lactate, central venous pressure (CVP), inferior vena cava collapsibility index, left ventricular ejection fraction (LVEF), and right heart load], post-weaning inflammatory markers at 1-day and 3-day [body temperature, white blood cell count (WBC), neutrophil percentage (NEU%), C-reactive protein (CRP), procalcitonin (PCT), interleukin-10 (IL-10)], as well as complications (infection, thrombosis, renal failure, gastrointestinal bleeding) and post-weaning blood return status were recorded. Patients were divided into an observation group (with post-weaning blood return) and a control group (without post-weaning blood return) based on the presence of blood return after weaning. The changes in the aforementioned parameters were compared between the two groups.</p><p><strong>Results: </strong>A total of 62 patients were included, with 31 cases in each group. No statistically significant differences were observed between the two groups in baseline characteristics including gender, age, BMI, and EuroScore. At weaning, the observation group exhibited relatively stable vital signs, with no significant differences in heart rate, SBP, DBP, or peripheral oxygen saturation compared to the control group. After weaning, the observation group showed significantly lower levels of BNP, PaCO<sub>2</sub>, arterial lactate, CVP, and right heart load compared to pre-weaning values [BNP (ng/L): 2 325.96±78.51 vs. 4 878.48±185.47, PaCO<sub>2</sub> (mmHg, 1 mmHg≈0.133 kPa): 35.23±3.25 vs. 40.75±4.41, arterial lactate (mmol/L): 2.43±0.61 vs. 6.19±1.31, CVP (cmH<sub>2</sub>O, 1 cmH<sub>2</sub>O≈0.098 kPa): 8.32±0.97 vs. 15.34±1.74, right heart load: 13.24±0.97 vs. 15.69±1.31, all P < 0.05], while Hb, PaO<sub>2</sub>, inferior vena cava collapsibility index, and LVEF were significantly higher than pre-weaning values [Hb (g/L): 104.42±9.78 vs. 96.74±6.39, PaO<sub>2</sub> (mmHg): 94.12±7.78 vs. 75.51±4.39, inferior vena cava collapsibility (%): 28±7 vs. 17±3, LVEF (%): 62","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"595-598"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[LncRNA-UCA1-microRNA-143-Notch1 regulates autophagy in myocardial ischemia reperfusion injury induced by cardiopulmonary bypass]. [LncRNA-UCA1-microRNA-143-Notch1调控体外循环诱导心肌缺血再灌注损伤的自噬]。
Q3 Medicine Pub Date : 2025-06-01 DOI: 10.3760/cma.j.cn121430-20240329-00298
Lingzhi Jiang, Mingshan Wang, Ye Shen

Objective: To observe the degree of myocardial cell injury and the changes in autophagy level in rats with myocardial ischemia/reperfusion (I/R) injury induced by cardiopulmonary bypass (CPB), and to explore the regulatory role of the long non-coding RNA-urothelial carcinoma antigen 1-microRNA-143-Notch1 axis (lncRNA-UCA1-miR-143-Notch1 axis) in myocardial I/R injury induced by CPB.

Methods: Healthy male Sprague-Dawley (SD) rats were randomly divided into the following groups using the random number method: Sham operation (Sham) group, myocardial I/R injury model group (model group), empty lentivirus group, lncRNA-UCA1 upregulation group, miR-143 downregulation group, and lncRNA-UCA1 upregulation+miR-143 upregulation group, with 9 rats in each group. The rat model of myocardial I/R injury induced by CPB was established by thoracotomy aortic ligation under cardiopulmonary bypass support; in the Sham group, only threading was performed without ligation, and other procedures were the same. Seventy-two hours before modeling, the lncRNA-UCA1 upregulated group was injected with 100 μL of myocardial tissue-specific adeno-associated virus (AAV) overexpression vector of lncRNA-UCA1 via tail vein, the miR-143 downregulated group was injected with 100 μL of AAV short hairpin RNA (shRNA) vector of miR-143 via tail vein, the lncRNA-UCA1 upregulation+miR-143 upregulation group was injected with 100 μL of myocardial tissue-AAV overexpression vector of lncRNA-UCA1 and 100 μL of AAV overexpression vector of miR-143 via tail vein, and the empty vector lentivirus group was injected with 100 μL of AAV empty vector (virus titers were 1×109 TU/mL); the Sham group and the model group were injected with equal amounts of normal saline. The animals were euthanized 24 hours after intervention and cardiac tissue specimens were collected. After hematoxylin eosin (HE) staining, the damage of myocardial cells and the changes of muscle fiber tissue were observed under a light microscope; after dual staining with uranyl acetate and lead citrate, the ultrastructural damage of heart tissue was observed under a transmission electron microscopy; the expression of lncRNA-UCA1, miR-143, and Notch1 mRNA in myocardial tissue was detected by real-time fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR); the expression of microtubule 1 light chain 3-II/I (LC3-II/I) and Notch1 protein in myocardial tissue was detected by Western blotting.

Results: Compared with the Sham group, the myocardial cells of rats in the model group were enlarged, the intercellular space increased, autophagosomes increased, the arrangement of myocardial fibers was disordered, mitochondrial proliferated and deformed. The expression levels of lncRNA-UCA1 and Notch1 mRNA, as well as the protein expression levels of LC3-II/I and Notch1 were significantly increased, while the expression level of miR-143 was signif

目的:观察体外循环(CPB)诱导心肌缺血/再灌注(I/R)损伤大鼠心肌细胞损伤程度及自噬水平的变化,探讨长链非编码rna -尿路上皮癌抗原1-microRNA-143-Notch1轴(lncRNA-UCA1-miR-143-Notch1轴)在CPB诱导心肌I/R损伤中的调控作用。方法:采用随机数法将健康雄性SD大鼠随机分为假手术组、心肌I/R损伤模型组、空慢病毒组、lncRNA-UCA1上调组、miR-143下调组、lncRNA-UCA1上调+miR-143上调组,每组9只。在体外循环支持下,采用开胸主动脉结扎法建立CPB致心肌I/R损伤大鼠模型;Sham组仅穿线,不结扎,其他操作相同。造模前72小时,lncRNA-UCA1上调组小鼠经尾静脉注射100 μL lncRNA-UCA1心肌组织特异性腺相关病毒(AAV)过表达载体,miR-143下调组小鼠经尾静脉注射100 μL miR-143 AAV短发夹RNA (shRNA)载体,lncRNA-UCA1上调+miR-143上调组经尾静脉注射100 μL心肌组织-AAV过表达载体lncRNA-UCA1和100 μL miR-143 AAV过表达载体,空载体慢病毒组注射100 μL AAV空载体(病毒滴度为1×109 TU/mL);假手术组和模型组大鼠均注射等量生理盐水。干预24小时后对大鼠实施安乐死,并采集心脏组织标本。苏木精伊红(HE)染色后,光镜下观察心肌细胞损伤情况及肌纤维组织变化;经醋酸铀酰和柠檬酸铅双重染色后,透射电镜观察心脏组织超微结构损伤;实时荧光定量逆转录聚合酶链反应(RT-PCR)检测心肌组织中lncRNA-UCA1、miR-143、Notch1 mRNA的表达;Western blotting检测心肌组织中微管1轻链3-II/I (LC3-II/I)和Notch1蛋白的表达。结果:与Sham组比较,模型组大鼠心肌细胞体积增大,细胞间隙增大,自噬体增多,心肌纤维排列紊乱,线粒体增生变形。lncRNA-UCA1和Notch1 mRNA表达水平以及LC3-II/I和Notch1蛋白表达水平显著升高,miR-143表达水平显著降低。与模型组比较,lncRNA-UCA1上调组和miR-143下调组心肌细胞损伤程度明显减轻,Notch1 mRNA、LC3-II/I、Notch1蛋白表达水平显著升高[Notch1 mRNA (2-ΔΔCt): 2.66±0.24、2.03±0.23 vs. 1.45±0.13,LC3-II/I: 2.10±0.21、1.92±0.19 vs. 1.39±0.14,Notch1蛋白(Notch1/GAPDH):1.72±0.16,1.57±0.16 vs 1.34±0.13,P均< 0.05],miR-143表达水平显著降低(2-ΔΔCt: 0.50±0.06,0.52±0.06 vs.0.71±0.06,P < 0.05)。lncRNA-UCA1上调组lncRNA-UCA1表达量显著高于模型组(2-ΔΔCt: 2.47±0.22 vs. 1.43±0.14,P < 0.05), miR-143下调组与模型组比较差异无统计学意义(2-ΔΔCt: 1.50±0.16 vs. 1.43±0.14,P < 0.05)。空载慢病毒组和lncRNA-UCA1上调+miR-143上调组的心肌细胞损伤程度与模型组比较无显著差异。与模型组比较,两组小鼠miR-143、Notch1 mRNA的表达及自噬水平均无显著差异。lncRNA-UCA1上调+miR-143上调组lncRNA-UCA1表达水平显著高于模型组(2-ΔΔCt: 2.47±0.20 vs. 1.43±0.14,P < 0.05)。结论:自噬参与了CPB致心肌I/R损伤的病理过程。lncRNA-UCA1-microRNA-143-Notch1轴可能调控自噬水平参与I/R损伤过程。
{"title":"[LncRNA-UCA1-microRNA-143-Notch1 regulates autophagy in myocardial ischemia reperfusion injury induced by cardiopulmonary bypass].","authors":"Lingzhi Jiang, Mingshan Wang, Ye Shen","doi":"10.3760/cma.j.cn121430-20240329-00298","DOIUrl":"10.3760/cma.j.cn121430-20240329-00298","url":null,"abstract":"<p><strong>Objective: </strong>To observe the degree of myocardial cell injury and the changes in autophagy level in rats with myocardial ischemia/reperfusion (I/R) injury induced by cardiopulmonary bypass (CPB), and to explore the regulatory role of the long non-coding RNA-urothelial carcinoma antigen 1-microRNA-143-Notch1 axis (lncRNA-UCA1-miR-143-Notch1 axis) in myocardial I/R injury induced by CPB.</p><p><strong>Methods: </strong>Healthy male Sprague-Dawley (SD) rats were randomly divided into the following groups using the random number method: Sham operation (Sham) group, myocardial I/R injury model group (model group), empty lentivirus group, lncRNA-UCA1 upregulation group, miR-143 downregulation group, and lncRNA-UCA1 upregulation+miR-143 upregulation group, with 9 rats in each group. The rat model of myocardial I/R injury induced by CPB was established by thoracotomy aortic ligation under cardiopulmonary bypass support; in the Sham group, only threading was performed without ligation, and other procedures were the same. Seventy-two hours before modeling, the lncRNA-UCA1 upregulated group was injected with 100 μL of myocardial tissue-specific adeno-associated virus (AAV) overexpression vector of lncRNA-UCA1 via tail vein, the miR-143 downregulated group was injected with 100 μL of AAV short hairpin RNA (shRNA) vector of miR-143 via tail vein, the lncRNA-UCA1 upregulation+miR-143 upregulation group was injected with 100 μL of myocardial tissue-AAV overexpression vector of lncRNA-UCA1 and 100 μL of AAV overexpression vector of miR-143 via tail vein, and the empty vector lentivirus group was injected with 100 μL of AAV empty vector (virus titers were 1×10<sup>9</sup> TU/mL); the Sham group and the model group were injected with equal amounts of normal saline. The animals were euthanized 24 hours after intervention and cardiac tissue specimens were collected. After hematoxylin eosin (HE) staining, the damage of myocardial cells and the changes of muscle fiber tissue were observed under a light microscope; after dual staining with uranyl acetate and lead citrate, the ultrastructural damage of heart tissue was observed under a transmission electron microscopy; the expression of lncRNA-UCA1, miR-143, and Notch1 mRNA in myocardial tissue was detected by real-time fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR); the expression of microtubule 1 light chain 3-II/I (LC3-II/I) and Notch1 protein in myocardial tissue was detected by Western blotting.</p><p><strong>Results: </strong>Compared with the Sham group, the myocardial cells of rats in the model group were enlarged, the intercellular space increased, autophagosomes increased, the arrangement of myocardial fibers was disordered, mitochondrial proliferated and deformed. The expression levels of lncRNA-UCA1 and Notch1 mRNA, as well as the protein expression levels of LC3-II/I and Notch1 were significantly increased, while the expression level of miR-143 was signif","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 6","pages":"576-582"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhonghua wei zhong bing ji jiu yi xue
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1